About / Executive Team / Granowitz

Craig Granowitz, MD, PhD
SVP, Chief Medical Officer

Dr. Granowitz joined Amarin in January 2016 with extensive experience managing a multi-national medical affairs organization for a portfolio of leading cardiovascular products. Prior to joining Amarin, Dr. Granowitz was senior vice president and head of global medical affairs, global human health at Merck, where he developed and implemented an entirely new global medical affairs organization following Merck’s merger with Schering-Plough. In this capacity, among his numerous achievements, he provided critical medical affairs support in the run-up to and read-out of Merck’s cardiovascular outcomes study, IMPROVE-IT. From 2003 to 2008, he was group vice president, head of global medical affairs for Schering-Plough.

Dr. Granowitz has been elected to serve on the Board of Directors of the New York City American Heart Association starting in June, 2017. Dr. Granowitz currently serves as a volunteer on the boards of directors of several organizations including the Columbia College of Physicians and Surgeons, the Rabbinical College of America and the American Associates of Ben Gurion University.



therapeutics to improve
cardiovascular health.

Join Our Mailing List

You may automatically receive Amarin Corporation plc financial information by email.

Click To Subscribe